EMEA-002474-PIP02-18-M02 - paediatric investigation plan

levonorgestrel
PIPHuman

Key facts

Active Substance
levonorgestrel
Therapeutic area
Surgical and medical procedures
Decision number
P/0163/2024
PIP number
EMEA-002474-PIP02-18-M02
Pharmaceutical form(s)
Vaginal delivery system
Condition(s) / indication(s)
Prevention of pregnancy
Route(s) of administration
Vaginal use
Contact for public enquiries

Chemo Research S.L.
E-mail: naomi.nunez@exeltis.com 
Tel.:  +34 653535412

Decision type
PM: decision on the application for modification of an agreed PIP
Decision date

Decision

Share this page